- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05235204
Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair
February 19, 2026 updated by: Karim Alavi
Patients undergoing surgical repair of colovesical fistula will have have "early" (post-operative day 3) cystogram and removal of bladder catheter.
Outcomes from the "early" group will be compared to historical "late" group data to determine if early bladder catheter removal is safe.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
There is defined time for foley/bladder catheter removal after colovesical fistula repair in the current surgical literature.
This study will be a prospective cohort study evaluating outcomes after early foley catheter removal (on post-operative day 3), specifically bladder leak, 30-day readmissions and adverse events.
This cohort will be compared to a retrospective "late" group, who had foley catheter removal later in their hospital course.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01605
- UMass Memorial Medical Center Memorial Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 18 and over
- Undergoing surgical repair of diverticular colovesical fistula
Exclusion Criteria:
- Patients with active and untreated genitourinary cancers
- Subjects with known or suspected Inflammatory Bowel Disease as the cause of colovesical fistula.
- Individuals who are not expected to regain normal bladder function after surgery as defined by either pre-existing bladder dysfunction with chronic indwelling urinary catheter, supra-pubic catheter, or surgical urinary diversion
- Individuals who require re-operation prior to Foley removal
- Adults unable to consent
- Pregnant women
- Prisoners
- Individuals who are not yet adults (infants, children, teenagers less than 18 years old)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Foley catheter removal day 2 or 3 post-operative procedure
According to review of internal clinical practices, the average duration of catheterization after Colovesical Fistula (CVF) repair is 10.8 days after CVF repair.
The intervention in this study removes the Foley Catheter at 2 to 3 days post CVF repair.
|
According to review of internal clinical practices, the average duration of catheterization after Colovesical Fistula (CVF) repair is 10.8 days after CVF repair.
The intervention in this study removes the Foley Catheter at 2 to 3 days post CVF repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of positive urine leak on post-operative day 3 cystogram
Time Frame: up to 3 days post surgery
|
Participants cystograms will be reviewed to detect positive urine leak, 2 to 3 days post surgery.
|
up to 3 days post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Foley catheter re-insertion
Time Frame: up to 5 days post-surgery
|
Participants who will require re-insertion of the foley catheter once it is removed on post-operative day 3
|
up to 5 days post-surgery
|
|
Re-operations within 30 days of initial surgery
Time Frame: up to 30 days post discharge
|
Patients who have required return to the OR within 30 days after discharge.
|
up to 30 days post discharge
|
|
Hospital re-admission
Time Frame: up to 30 days post- discharge
|
Patients who have required readmission to the hospital within 30 days after discharge.
|
up to 30 days post- discharge
|
|
Symptomatic post-operative urinary tract infection
Time Frame: up to days post discharge
|
Patients who have had a symptomatic urinary tract infection within 30 days after discharge.
|
up to days post discharge
|
|
Post operative urinary sepsis
Time Frame: up to 30 days post discharge
|
Patients who have urinary sepsis either prior to discharge or within 30 days after discharge.
|
up to 30 days post discharge
|
|
Recurrence of colovesical fistula
Time Frame: up to 30 days post-discharge
|
Patients who had recurrence of their colovesical fistula within 30 days of discharge.
|
up to 30 days post-discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: KArin Alavi, MD, MPH, UMass Chan Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2019
Primary Completion (Actual)
January 31, 2026
Study Completion (Actual)
January 31, 2026
Study Registration Dates
First Submitted
December 16, 2021
First Submitted That Met QC Criteria
February 10, 2022
First Posted (Actual)
February 11, 2022
Study Record Updates
Last Update Posted (Actual)
February 20, 2026
Last Update Submitted That Met QC Criteria
February 19, 2026
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H00016345
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colovesical Fistula
-
Mount Carmel Health SystemCompletedColovesical FistulaUnited States
-
National and Kapodistrian University of AthensRecruitingAnal Fistula | Perianal Fistula | Anal Fistula SurgeryGreece
-
London North West Healthcare NHS TrustCompletedFistula in Ano | Ano FistulaUnited Kingdom
-
Rush University Medical CenterTerminatedRectal Fistula | Anal Fistula | Fistula in Ano | Transsphincteric FistulaUnited States
-
William A. Faubion, M.D.CompletedPerianal Fistula | Cryptoglandular Perianal Fistula | Crohn's Perianal FistulaUnited States
-
Islamabad Medical and Dental CollegeCompletedAnal Fistula | Perianal Fistula | Fistula-in-anoPakistan
-
Tehran University of Medical SciencesRecruitingFistula PerianalIran, Islamic Republic of
-
Sykehuset Innlandet HFWithdrawn
-
Tehran University of Medical SciencesNot yet recruiting
-
University Hospital, AkershusUniversity Hospital, Linkoeping; Region Örebro County; Uppsala University HospitalCompletedPerianal FistulaNorway